Machine Perfusion Beats Cold Storage
Hypothermic machine perfusion of deceased donor kidneys is associated with better transplantation outcomes than cold storage of the organs in the first year following the procedure, a study found.
Hypothermic machine perfusion of deceased donor kidneys is associated with better transplantation outcomes than cold storage of the organs in the first year following the procedure, a study found.
Urologic malignancy is the most common cause of hematuria following renal transplantation, according to an investigation conducted in Taiwan.
The risk of a man’s developing prostate cancer is approximately 18%. Whereas it has been estimated that as much as 60% of this risk is due to environmental exposure (J Urol. 2007;178:S9-S13), developing strategies to mitigate this risk is an important public heath concern.
John P. Mulhall, MD, director of the Male Sexual and Reproductive Medicine Program at Memorial Sloan-Kettering Cancer Center in New York City, has written a new book titled Saving Your Sex Life: A Guide for Men with Prostate Cancer (Hilton Publishing Company, Chicago, 2008).
In the past year, an important landmark study demonstrated therapeutic equivalence of the ACE inhibitor ramipril and the angiotensin receptor blocker (ARB) telmisartan in reducing the risk of all forms of atherosclerotic events.
PHILADELPHIA—Researchers say they may have identified a novel approach to treating renal cell carcinoma (RCC). It involves using compounds that block a cancer gene’s repair mechanism so that chemotherapy is more effective.
SAN FRANCISCO—The incidence of end-stage renal disease (ESRD) due to lupus nephritis (LN) rose significantly in the United States from 1995 to 2004, according to new study data presented here at the American College of Rheumatology annual meeting. The incidence was significantly higher among African Americans and women.
SAN FRANCISCO—Conventional treatments for bladder cancer may be inappropriate in elderly patients because of underlying age-related functional impairment and comorbidities, according to a medical oncologist.